Clinical Trial Update: A Bridging Study of the SYN023 on Healthy Adult Subjects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 bridging study of SYN023 in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Communicable Diseases
• Zoonotic Diseases

Drugs mentioned

• SYN023 (SYN023)

Snippet

Sponsor: Synermore Biologics (Suzhou) Co., Ltd. | Conditions: Communicable Disease Transmission, Zoonotic Disease | Phase 1, Phase 2 | Status: COMPLETED